JNJ-53718678
CR107945
Phase 1 small_molecule terminated
Quick answer
JNJ-53718678 for Respiratory Syncytial Virus Infections is a Phase 1 program (small_molecule) at Janssen Cilag International NV with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Janssen Cilag International NV
- Indication
- Respiratory Syncytial Virus Infections
- Phase
- Phase 1
- Modality
- small_molecule
- Status
- terminated